Xenon Pharmaceuticals Inc (XENE)
Healthcare
Biotechnology
62.30 $
-0.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Xenon Pharmaceuticals Inc (XENE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -89 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -33 | -42 | -35 | -46 | -33 | -50 | -54 | -62 | -64 | -72 | -81 | -89 | -306 | |
| 0.6 | 1.7 | 0.9 | 0.6 | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 2.5 | |
| 8.5 | 8.7 | 9.2 | 9.4 | 15 | 13 | 14 | 12 | 14 | 14 | 14 | 17 | 58 | |
| 6.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.9 | -3.3 | -0.5 | -5.9 | 0.9 | -0.3 | 2.2 | -12 | 2.6 | 5.0 | 9.0 | -3.4 | 13 | |
| 2.1 | 1.2 | 0.1 | 0.2 | 1.5 | 0.6 | 0.8 | 0.0 | 0.2 | 0.3 | 0.3 | 0.1 | 0.9 | |
| 28 | 48 | -240 | -43 | 111 | 0.5 | 99 | 35 | 82 | 39 | 63 | -407 | -224 | |
| 0.0 | 30 | 324 | 0.0 | 0.0 | 0.0 | 12 | 1.2 | 0.1 | 2.4 | 114 | 843 | 959 | |
| -5.0 | 35 | 49 | -90 | 78 | -49 | 55 | -26 | 19 | -31 | 95 | 347 | 429 | |
| -35 | -43 | -36 | -46 | -34 | -50 | -55 | -62 | -64 | -72 | -82 | -89 | -307 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.